Citations (131)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mishra Shashank Shekhar, T. Venkatachalam, Chandra Shekhar Sharma, Hemendra Pratap Singh, Sourav Kalra & Neeraj Kumar. (2019) Computational investigation of binding mechanism of substituted pyrazinones targeting corticotropin releasing factor-1 receptor deliberated for anti-depressant drug design. Journal of Biomolecular Structure and Dynamics 37:12, pages 3226-3244.
Read now
Read now
Neeraj Kumar, Shashank Shekhar Mishra, Chandra Shekhar Sharma, Hamendra Pratap Singh & Sourav Kalra. (2018)
In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation. Journal of Biomolecular Structure and Dynamics 36:7, pages 1691-1712.
Read now
Read now
Rowan A. Stringer, Eckhard Weber, Andrew Culshaw, Jeff McKenna, Gareth Williams, Jonathan Rose & Bindi Sohal. (2014) Preclinical metabolism and pharmacokinetics of NVS-CRF38, a potent and orally bioavailable corticotropin-releasing factor receptor 1 antagonist. Xenobiotica 44:10, pages 902-912.
Read now
Read now
Marcelo Paez-Pereda, Felix Hausch & Florian Holsboer. (2011) Corticotropin releasing factor receptor antagonists for major depressive disorder. Expert Opinion on Investigational Drugs 20:4, pages 519-535.
Read now
Read now
Susan K Wood & James H Woods. (2007) Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances. Expert Opinion on Therapeutic Targets 11:11, pages 1401-1413.
Read now
Read now
Dimitri E Grigoriadis. (2005) The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders. Expert Opinion on Therapeutic Targets 9:4, pages 651-684.
Read now
Read now
Raye Z Litten, Joanne Fertig, Margaret Mattson & Mark Egli. (2005) Development of medications for alcohol use disorders: recent advances and ongoing challenges. Expert Opinion on Emerging Drugs 10:2, pages 323-343.
Read now
Read now
Articles from other publishers (124)
Xin Yang & Fei Geng. (2023) Corticotropin‐releasing factor signaling and its potential role in the prefrontal cortex‐dependent regulation of anxiety. Journal of Neuroscience Research.
Crossref
Crossref
Hongyue Wang, Jinping Hu, Jiahuan Hu, Qiuyu Chen, Nianying Shang, Mengyao Liu, Xinnan Li, Longgang Xiang, Dali Yin, Jiaqi Lan, Qiong Xiao & Ying Peng. (2023) Antidepressant effect of 4-Butyl-alpha-agarofuran via HPA axis and serotonin system. Brain Research Bulletin 198, pages 3-14.
Crossref
Crossref
Rachel Chudoba & Joanna Dabrowska. (2023) Distinct populations of corticotropin-releasing factor (CRF) neurons mediate divergent yet complementary defensive behaviors in response to a threat. Neuropharmacology 228, pages 109461.
Crossref
Crossref
Mehmet Bülbül & Osman Sinen. (2022) The influence of early-life and adulthood stressors on brain neuropeptide-S system. Neuropeptides 92, pages 102223.
Crossref
Crossref
Mehmet Bülbül & Osman Sinen. (2021) Centrally Administered Neuropeptide‐S Alleviates Gastrointestinal Dysmotility Induced by Neonatal Maternal Separation. Neurogastroenterology & Motility 34:1.
Crossref
Crossref
Terence Y. Pang, Jazmine D.W. Yaeger, Cliff H. Summers & Rupshi Mitra. (2021) Cardinal role of the environment in stress induced changes across life stages and generations. Neuroscience & Biobehavioral Reviews 124, pages 137-150.
Crossref
Crossref
Valentina Vozella, Bryan Cruz, Luis A. Natividad, Federica Benvenuti, Nazzareno Cannella, Scott Edwards, Eric P. Zorrilla, Roberto Ciccocioppo & Marisa Roberto. (2021) Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats. International Journal of Molecular Sciences 22:6, pages 3095.
Crossref
Crossref
Cesar R. Romero-Leguizamón & Kristi A. Kohlmeier. (2020) Stress-related endogenous neuropeptides induce neuronal excitation in the Laterodorsal Tegmentum. European Neuropsychopharmacology 38, pages 86-97.
Crossref
Crossref
Sierra Simpson, Kokila Shankar, Adam Kimbrough & Olivier George. (2020) Role of corticotropin-releasing factor in alcohol and nicotine addiction. Brain Research 1740, pages 146850.
Crossref
Crossref
Elena Martínez-Laorden, Javier Navarro-Zaragoza, María Victoria Milanés, María Luisa Laorden & Pilar Almela. (2020) Cardiac Protective Role of Heat Shock Protein 27 in the Stress Induced by Drugs of Abuse. International Journal of Molecular Sciences 21:10, pages 3623.
Crossref
Crossref
Jung S. Kim & Rémi Martin‐Fardon. (2020) Possible Role of CRF‐Hcrt Interaction in the Infralimbic Cortex in the Emergence and Maintenance of Compulsive Alcohol‐Seeking Behavior. Alcoholism: Clinical and Experimental Research 44:2, pages 354-367.
Crossref
Crossref
Geoffrey Canet, Célia Hernandez, Charleine Zussy, Nathalie Chevallier, Catherine Desrumaux & Laurent Givalois. (2019) Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Nazzareno Cannella, Massimo Ubaldi, Alessio Masi, Massimo Bramucci, Marisa Roberto, Angelo Bifone & Roberto Ciccocioppo. (2019) Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neuroscience & Biobehavioral Reviews 103, pages 384-398.
Crossref
Crossref
S. A. Wolfe, H. Sidhu, R. R. Patel, M. Kreifeldt, S. R. D’Ambrosio, C. Contet & M. Roberto. (2019) Molecular, Morphological, and Functional Characterization of Corticotropin-Releasing Factor Receptor 1-Expressing Neurons in the Central Nucleus of the Amygdala. eneuro 6:3, pages ENEURO.0087-19.2019.
Crossref
Crossref
Chakravarthi Narla, Paul S. Jung, Francisco Bautista Cruz, Michelle Everest, Julio Martinez-Trujillo & Michael O. Poulter. (2019) CRF Mediates Stress-Induced Pathophysiological High-Frequency Oscillations in Traumatic Brain Injury. eneuro 6:2, pages ENEURO.0334-18.2019.
Crossref
Crossref
Kristen E. Pleil & Mary Jane Skelly. (2018) CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety. Alcohol 72, pages 33-47.
Crossref
Crossref
Takuto Kojima, Michiyo Mochizuki, Takafumi Takai, Yasutaka Hoashi, Sachie Morimoto, Masaki Seto, Minoru Nakamura, Katsumi Kobayashi, Yuu Sako, Maiko Tanaka, Naoyuki Kanzaki, Yohei Kosugi, Takahiko Yano & Kazuyoshi Aso. (2018) Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists. Bioorganic & Medicinal Chemistry 26:9, pages 2229-2250.
Crossref
Crossref
Hongxin Dong, Jack M. Keegan, Ellie Hong, Christopher Gallardo, Janitza Montalvo-Ortiz, Becky Wang, Kenner C. Rice & John Csernansky. (2018) Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats. Psychoneuroendocrinology 90, pages 92-101.
Crossref
Crossref
Carmen Ferrer-Pérez, Marina D. Reguilón, Carmen Manzanedo, M. Asunción Aguilar, José Miñarro & Marta Rodríguez-Arias. (2018) Antagonism of corticotropin-releasing factor CRF 1 receptors blocks the enhanced response to cocaine after social stress. European Journal of Pharmacology 823, pages 87-95.
Crossref
Crossref
Sabra S. Inslicht, Madhu N. Rao, Anne Richards, Aoife O’Donovan, Carolyn J. Gibson, Tierney Baum, Thomas J. Metzler & Thomas C. Neylan. (2018) Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder. Psychoneuroendocrinology 88, pages 136-143.
Crossref
Crossref
Eugene Klimov, Artemii Tretiakov, Olga Rudko, Anna Soboleva, Ivan Danilin, Irina Korsunskaya & Vladimir Sobolev. (2018) Psychodermatology: a molecular link between psoriasis and anxiety disorder. Acta Dermatovenerologica Alpina Pannonica et Adriatica 27:4.
Crossref
Crossref
Angelo Contarino, Pierre Kitchener, Monique Vallée, Francesco Papaleo & Pier-Vincenzo Piazza. (2017) CRF1 receptor-deficiency increases cocaine reward. Neuropharmacology 117, pages 41-48.
Crossref
Crossref
Samantha R. Spierling & Eric P. Zorrilla. (2017) Don’t stress about CRF: assessing the translational failures of CRF1antagonists. Psychopharmacology 234:9-10, pages 1467-1481.
Crossref
Crossref
Marisa Roberto, Samantha R. Spierling, Dean Kirson & Eric P. Zorrilla. 2017. The Role of Neuropeptides in Addiction and Disorders of Excessive Consumption. The Role of Neuropeptides in Addiction and Disorders of Excessive Consumption
5
51
.
E.P. Zorrilla. 2017. Stress: Neuroendocrinology and Neurobiology. Stress: Neuroendocrinology and Neurobiology
265
277
.
Alba Vicario, Ezequiel Mendoza, Antonio Abellán, Constance Scharff & Loreta Medina. (2016) Genoarchitecture of the extended amygdala in zebra finch, and expression of FoxP2 in cell corridors of different genetic profile. Brain Structure and Function 222:1, pages 481-514.
Crossref
Crossref
Fernanda L. Galesi, Lydia O. Ayanwuyi, Miriam Garcia Mijares, Andrea Cippitelli, Nazzareno Cannella, Roberto Ciccocioppo & Massimo Ubaldi. (2016) Role of Hypothalamic-Pituitary-Adrenal axis and corticotropin-releasing factor stress system on cue-induced relapse to alcohol seeking. European Journal of Pharmacology 788, pages 84-89.
Crossref
Crossref
Michiyo Mochizuki, Masakuni Kori, Katsumi Kobayashi, Takahiko Yano, Yuu Sako, Maiko Tanaka, Naoyuki Kanzaki, Albert C. Gyorkos, Christopher P. Corrette, Suk Young Cho, Scott A. Pratt & Kazuyoshi Aso. (2016) Design and Synthesis of Benzimidazoles As Novel Corticotropin-Releasing Factor 1 Receptor Antagonists. Journal of Medicinal Chemistry 59:6, pages 2551-2566.
Crossref
Crossref
Sang Jeon & Yong-Ku Kim. (2016) Molecular Neurobiology and Promising New Treatment in Depression. International Journal of Molecular Sciences 17:3, pages 381.
Crossref
Crossref
Glenn R. Valdez. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
751
764
.
Mailton Vasconcelos, Dirson João Stein & Rosa Maria M. de Almeida. (2015) Social defeat protocol and relevant biomarkers, implications for stress response physiology, drug abuse, mood disorders and individual stress vulnerability: a systematic review of the last decade. Trends in Psychiatry and Psychotherapy 37:2, pages 51-66.
Crossref
Crossref
Oscar Delgado, Francisca Delgado, Juan Antonio Vega & Andrés A. Trabanco. (2015) N-bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders. European Journal of Medicinal Chemistry 97, pages 719-731.
Crossref
Crossref
Andrea Cippitelli, Lydia O. Ayanwuyi, Estelle Barbier, Esi Domi, Jose M. Lerma-Cabrera, Francisca Carvajal, Giulia Scuppa, Hongwu Li, Massimo Ubaldi, Markus Heilig, Marisa Roberto & Roberto Ciccocioppo. (2014) Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats. Psychopharmacology 232:6, pages 1083-1093.
Crossref
Crossref
Yvette Taché & Mulugeta Million. (2015) Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia. Journal of Neurogastroenterology and Motility 21:1, pages 008-024.
Crossref
Crossref
T. J. Phillips, C. Reed & R. Pastor. (2015) Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation. Genes, Brain and Behavior 14:1, pages 98-135.
Crossref
Crossref
Hongxin Dong, Shirlene Wang, Ziling Zeng, Fei Li, Janitza Montalvo-Ortiz, Christopher Tucker, Shahzad Akhtar, Jingshan Shi, Herbert Y. Meltzer, Kenner C. Rice & John G. Csernansky. (2014) Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. Psychopharmacology 231:24, pages 4711-4722.
Crossref
Crossref
S. V. Sotnikov, N. Y. Chekmareva, B. Schmid, D. Harbich, V. Malik, S. Bauer, C. Kuehne, P. O. Markt, J. M. Deussing, M. V. Schmidt & R. Landgraf. (2014)
Enriched environment impacts trimethylthiazoline-induced anxiety-related behavior and immediate early gene expression: critical role of
Crhr1
. European Journal of Neuroscience 40:4, pages 2691-2700.
Crossref
Crossref
Eric P. Zorrilla, Marian L. Logrip & George F. Koob. (2014) Corticotropin releasing factor: A key role in the neurobiology of addiction. Frontiers in Neuroendocrinology 35:2, pages 234-244.
Crossref
Crossref
T. N. Douma, M. J. Millan, D. Boulay, G. Griebel, P. M. Verdouw, K. G. Westphal, B. Olivier & L. Groenink. (2013) CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents. Psychopharmacology 231:7, pages 1289-1303.
Crossref
Crossref
J. Navarro-Zaragoza, E. Martínez-Laorden, L. Mora, J. Hidalgo, M.V. Milanés & M.L. Laorden. (2014) Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: Role of corticotropin-releasing factor (CRF) 1 receptor. Toxicology and Applied Pharmacology 275:1, pages 28-35.
Crossref
Crossref
Dervla O’Malley, Marcela Julio-Piepera,Timothy G. Dinan & John F. Cryan. (2014) Strain differences in stress-induced changes in central CRF1 receptor expression. Neuroscience Letters 561, pages 192-197.
Crossref
Crossref
Valentina Sabino, Jina Kwak, Kenner C. Rice & Pietro Cottone. (2013) Pharmacological Characterization of the 20% Alcohol Intermittent Access Model in Sardinian Alcohol-Preferring Rats: A Model of Binge-Like Drinking. Alcoholism: Clinical and Experimental Research 37:4, pages 635-643.
Crossref
Crossref
C. Jee, J. Lee, J. P. Lim, D. Parry, R. O. Messing & S. L. McIntire. (2012)
SEB
‐3, a
CRF
receptor‐like
GPCR
, regulates locomotor activity states, stress responses and ethanol tolerance in
Caenorhabditis
elegans
. Genes, Brain and Behavior 12:2, pages 250-262.
Crossref
Crossref
K S Sink, D L Walker, S M Freeman, E I Flandreau, K J Ressler & M Davis. (2012) Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Molecular Psychiatry 18:3, pages 308-319.
Crossref
Crossref
Eric P. Zorrilla, Markus Heilig, Harriet de Wit & Yavin Shaham. (2013) Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism. Drug and Alcohol Dependence 128:3, pages 175-186.
Crossref
Crossref
Tom Rouwette, Pascal Vanelderen, Eric Roubos, Tamás Kozicz & Kris Vissers. (2013) De amygdala, een schakelstation voor het aan- en uitzetten van pijn: de rol van limbisch corticotropin-releasing factor bij neuropathische pijn. Neuropraxis 17:1, pages 3-9.
Crossref
Crossref
Lara S. Hwa, Joseph F. DeBold & Klaus A. Miczek. (2012) Alcohol in excess: CRF1 receptors in the rat and mouse VTA and DRN. Psychopharmacology 225:2, pages 313-327.
Crossref
Crossref
Xiao-Dong Wang, Christiana Labermaier, Florian Holsboer, Wolfgang Wurst, Jan M. Deussing, Marianne B. Müller & Mathias V. Schmidt. (2012) Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1. European Journal of Neuroscience 36:3, pages 2360-2367.
Crossref
Crossref
Johannes Breu, Chadi Touma, Sabine M. Hölter, Alana Knapman, Wolfgang Wurst & Jan M. Deussing. (2012) Urocortin 2 modulates aspects of social behaviour in mice. Behavioural Brain Research 233:2, pages 331-336.
Crossref
Crossref
Susan K. Wood, Kile V. McFadden, Dimitri Grigoriadis, Seema Bhatnagar & Rita J. Valentino. (2012) Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor. Psychopharmacology 222:2, pages 325-336.
Crossref
Crossref
T. Rouwette, P. Vanelderen, E.W. Roubos, T. Kozicz & K. Vissers. (2011) The amygdala, a relay station for switching on and off pain. European Journal of Pain 16:6, pages 782-792.
Crossref
Crossref
Eric P. Zorrilla, Sunmee Wee, Yu Zhao, Sheila Specio, Benjamin Boutrel, George F. Koob & Friedbert Weiss. (2011) Extended access cocaine self‐administration differentially activates dorsal raphe and amygdala corticotropin‐releasing factor systems in rats. Addiction Biology 17:2, pages 300-308.
Crossref
Crossref
Juan-Antonio Garcia-Carmona, Pilar Almela, Alberto Baroja-Mazo, M. Victoria Milanes & M. Luisa Laorden. (2011) Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal. Psychopharmacology 220:2, pages 379-393.
Crossref
Crossref
Limor Regev, Michael Tsoory, Shosh Gil & Alon Chen. (2012) Site-Specific Genetic Manipulation of Amygdala Corticotropin-Releasing Factor Reveals Its Imperative Role in Mediating Behavioral Response to Challenge. Biological Psychiatry 71:4, pages 317-326.
Crossref
Crossref
Yehezkel Sztainberg & Alon Chen. 2012. Handbook of Neuroendocrinology. Handbook of Neuroendocrinology
355
375
.
Yehezkel Sztainberg, Yael Kuperman, Nicholas Justice & Alon Chen. (2011) An Anxiolytic Role for CRF Receptor Type 1 in the Globus Pallidus. The Journal of Neuroscience 31:48, pages 17416-17424.
Crossref
Crossref
Darin J. Knapp, David H. Overstreet, Mae Huang, Tiffany A. Wills, Buddy A. Whitman, Robert A. Angel, Sarah E. Sinnett & George R. Breese. (2011) Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology 218:1, pages 179-189.
Crossref
Crossref
Raúl Pastor, Cheryl Reed, Sue Burkhart-Kasch, Na Li, Amanda L. Sharpe, Sarah C. Coste, Mary P. Stenzel-Poore & Tamara J. Phillips. (2011) Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice. Psychopharmacology 218:1, pages 169-177.
Crossref
Crossref
Cecilio Lopez-Munoz & Francisco AlamoGlenn Valdez. 2011. Neurobiology of Depression. Neurobiology of Depression
275
292
.
L Regev, A Neufeld-Cohen, M Tsoory, Y Kuperman, D Getselter, S Gil & A Chen. (2010) Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Molecular Psychiatry 16:7, pages 714-728.
Crossref
Crossref
Marian L. Logrip, George F. Koob & Eric P. Zorrilla. (2011) Role of Corticotropin-Releasing Factor in Drug Addiction. CNS Drugs 25:4, pages 271-287.
Crossref
Crossref
Dervla O’Malley, Timothy G. Dinan & John F. Cryan. (2010) Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthood. Psychopharmacology 214:1, pages 221-229.
Crossref
Crossref
G. Fink. (2011) Stress Controversies: Post-Traumatic Stress Disorder, Hippocampal Volume, Gastroduodenal Ulceration*. Journal of Neuroendocrinology 23:2, pages 107-117.
Crossref
Crossref
Patrick J. Ronan & Cliff H. Summers. 2011. The Brain as a Drug Target. The Brain as a Drug Target
235
292
.
Y Sztainberg, Y Kuperman, M Tsoory, M Lebow & A Chen. (2010) The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1. Molecular Psychiatry 15:9, pages 905-917.
Crossref
Crossref
Supriyo Bhattacharya, Govindan Subramanian, Spencer Hall, Jianping Lin, Abdelazize Laoui & Nagarajan Vaidehi. (2010) Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1. Journal of Computer-Aided Molecular Design 24:8, pages 659-674.
Crossref
Crossref
Javier Navarro-Zaragoza, Cristina Núñez, M. Luisa Laorden & M. Victoria Milanés. (2010) Effects of Corticotropin-Releasing Factor Receptor-1 Antagonists on the Brain Stress System Responses to Morphine Withdrawal. Molecular Pharmacology 77:5, pages 864-873.
Crossref
Crossref
d. o'malley, m. julio-pieper, s. m. gibney, r. d. gosselin, t. g. dinan & j. f. cryan. (2010) Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. Neurogastroenterology & Motility 22:3, pages 301-311.
Crossref
Crossref
Rémi Martin-Fardon, Eric P. Zorrilla, Roberto Ciccocioppo & Friedbert Weiss. (2010) Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Research 1314, pages 145-161.
Crossref
Crossref
Ullrich Wagner & Jan Born. 2010. Neuropsychologie psychischer Störungen. Neuropsychologie psychischer Störungen
121
143
.
C.L. Pickens, T. Adams-Deutsch, S.G. Nair, B.M. Navarre, M. Heilig & Y. Shaham. (2009) Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear. Neuroscience 164:4, pages 1398-1406.
Crossref
Crossref
Pietro CottoneValentina SabinoMarisa Roberto, Michal BajoLara PockrosJennifer B. FrihaufEva M. Fekete, Luca SteardoKenner C. Rice, Dimitri E. Grigoriadis, Bruno ContiGeorge F. KoobEric P. Zorrilla. (2009) CRF system recruitment mediates dark side of compulsive eating. Proceedings of the National Academy of Sciences 106:47, pages 20016-20020.
Crossref
Crossref
David Stacey, Toni-Kim Clarke & Gunter Schumann. (2009) The genetics of alcoholism. Current Psychiatry Reports 11:5, pages 364-369.
Crossref
Crossref
Toni-Kim Clarke & Gunter Schumann. (2009) Gene–environment interactions resulting in risk alcohol drinking behaviour are mediated by CRF and CRF1. Pharmacology Biochemistry and Behavior 93:3, pages 230-236.
Crossref
Crossref
É.M. Fekete, Y. Zhao, C. Li, V. Sabino, W.W. Vale & E.P. Zorrilla. (2009) Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA. Neuroscience 162:1, pages 5-13.
Crossref
Crossref
Konstantinos A. Paschos, George Kolios & Ekaterini Chatzaki. (2009) The corticotropin-releasing factor system in inflammatory bowel disease: Prospects for new therapeutic approaches. Drug Discovery Today 14:13-14, pages 713-720.
Crossref
Crossref
Victoria B Risbrough, Mark A Geyer, Richard L Hauger, Sarah Coste, Mary Stenzel-Poore, Wolfgang Wurst & Florian Holsboer. (2008) CRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues. Neuropsychopharmacology 34:6, pages 1494-1503.
Crossref
Crossref
Thomas N. Greenwell, Cindy K. Funk, Pietro Cottone, Heather N. Richardson, Scott A. Chen, Kenner C. Rice, Eric P. Zorrilla & George F. Koob. (2009) Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addiction Biology 14:2, pages 130-143.
Crossref
Crossref
Andreas StengelYvette Taché. (2009) Neuroendocrine Control of the Gut During Stress: Corticotropin-Releasing Factor Signaling Pathways in the Spotlight. Annual Review of Physiology 71:1, pages 219-239.
Crossref
Crossref
Thomas Steckler. 2010. Behavioral Neurobiology of Anxiety and Its Treatment. Behavioral Neurobiology of Anxiety and Its Treatment
415
428
.
Yvette Tach�� & Stefan Brunnhuber. (2008) From Hans Selye's Discovery of Biological Stress to the Identification of Corticotropin- Releasing Factor Signaling Pathways. Annals of the New York Academy of Sciences 1148:1, pages 29-41.
Crossref
Crossref
John H. Kehne & George D. Maynard. (2008) CRF1 receptor antagonists: treatment of stress-related disorders. Drug Discovery Today: Therapeutic Strategies 5:3, pages 161-168.
Crossref
Crossref
Sudhir N. Umathe, Pravinkumar S. Bhutada, Nishant S. Jain, Pankaj V. Dixit & Manish M. Wanjari. (2008) Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behavioural Pharmacology 19:4, pages 308-316.
Crossref
Crossref
Srijan Sen & Gerard Sanacora. (2008) Major depression: emerging therapeutics. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:3, pages 204-225.
Crossref
Crossref
Sanjay J. Mathew, Rebecca B. Price & Dennis S. Charney. (2008) Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 148C:2, pages 89-98.
Crossref
Crossref
Xiaoju Yang, Shelun Wang, Kenner C. Rice, Cynthia A. Munro & Gary S. Wand. (2008) Restraint Stress and Ethanol Consumption in Two Mouse Strains. Alcoholism: Clinical and Experimental Research 32:5, pages 840-852.
Crossref
Crossref
Yael Kuperman & Alon Chen. (2008) Urocortins: emerging metabolic and energy homeostasis perspectives. Trends in Endocrinology & Metabolism 19:4, pages 122-129.
Crossref
Crossref
Fiona Thomson & Mark Craighead. (2007) Innovative Approaches for the Treatment of Depression: Targeting the HPA Axis. Neurochemical Research 33:4, pages 691-707.
Crossref
Crossref
Dennis R. Sparta, Angela M. Sparrow, Emily G. Lowery, Jon R. Fee, Darin J. Knapp & Todd E. Thiele. (2008) Blockade of the Corticotropin Releasing Factor Type 1 Receptor Attenuates Elevated Ethanol Drinking Associated With Drinking in the Dark Procedures. Alcoholism: Clinical and Experimental Research 32:2, pages 259-265.
Crossref
Crossref
Emily G. Lowery, Angela M. Sparrow, George R. Breese, Darin J. Knapp & Todd E. Thiele. (2008) The CRF-1 Receptor Antagonist, CP-154,526, Attenuates Stress-Induced Increases in Ethanol Consumption by BALB/cJ Mice. Alcoholism: Clinical and Experimental Research 32:2, pages 240-248.
Crossref
Crossref
Sheila E. Specio, Sunmee Wee, Laura E. O’Dell, Benjamin Boutrel, Eric P. Zorrilla & George F. Koob. (2007) CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology 196:3, pages 473-482.
Crossref
Crossref
George F. KoobMichel Le Moal. (2008) Addiction and the Brain Antireward System. Annual Review of Psychology 59:1, pages 29-53.
Crossref
Crossref
Thomas Steckler. 2008. Handbook of Anxiety and Fear. Handbook of Anxiety and Fear
157
221
.
Y. Zhao, G. R. Valdez, É. M. Fekete, J. E. Rivier, W. W. Vale, K. C. Rice, F. Weiss & E. P. Zorrilla. (2007) Subtype-Selective Corticotropin-Releasing Factor Receptor Agonists Exert Contrasting, but Not Opposite, Effects on Anxiety-Related Behavior in Rats. Journal of Pharmacology and Experimental Therapeutics 323:3, pages 846-854.
Crossref
Crossref
D.T. Hubbard, B.R. Nakashima, I. Lee & L.K. Takahashi. (2007) Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience 150:4, pages 818-828.
Crossref
Crossref
p.-q. yuan, m. million, s. v. wu, j. rivier & y. taché. (2007)
Peripheral corticotropin releasing factor (CRF) and a novel CRF
1
receptor agonist, stressin
1
-A activate CRF
1
receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats
. Neurogastroenterology & Motility 19:11, pages 923-936.
Crossref
Crossref
Olivier George, Sandy Ghozland, Marc R. Azar, Pietro Cottone, Eric P. Zorrilla, Loren H. Parsons, Laura E. O'Dell, Heather N. Richardson & George F. Koob. (2007)
CRF–CRF
1
system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats
. Proceedings of the National Academy of Sciences 104:43, pages 17198-17203.
Crossref
Crossref
A. Tabarin, Y. Diz-Chaves, D. Consoli, M. Monsaingeon, T. L. Bale, M. D. Culler, R. Datta, F. Drago, W. W. Vale, G. F. Koob, E. P. Zorrilla & A. Contarino. (2007) Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. European Journal of Neuroscience 26:8, pages 2303-2314.
Crossref
Crossref
Akihito Watanabe, Shiro Okuno, Mai Okano, Shaun Jordan, Koutoku Aihara, Takeshi K. Watanabe, Yuki Yamasaki, Hisashi Kitagawa, Kiyoshi Sugawara & Satoru Kato. (2007) Altered emotional behaviors in the diabetes mellitus OLETF type 1 congenic rat. Brain Research 1178, pages 114-124.
Crossref
Crossref
Laura Mattioli & Marina Perfumi. (2006) Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats. Journal of Psychopharmacology 21:7, pages 742-750.
Crossref
Crossref
Marcus Ising, Ulrich S Zimmermann, Heike E Künzel, Manfred Uhr, Alan C Foster, Susan M Learned-Coughlin, Florian Holsboer & Dimitri E Grigoriadis. (2007) High-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response. Neuropsychopharmacology 32:9, pages 1941-1949.
Crossref
Crossref
Gabriella Gentile, Romano Di Fabio, Francesca Pavone, Fabio Maria Sabbatini, Yves St-Denis, Maria Grazia Zampori, Giovanni Vitulli & Angela Worby. (2007) Novel substituted tetrahydrotriazaacenaphthylene derivatives as potent CRF1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 17:18, pages 5218-5221.
Crossref
Crossref
Cindy K. Funk & George F. Koob. (2007) A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Research 1155, pages 172-178.
Crossref
Crossref
Roberto Arban, Roberto Benedetti, Giorgio Bonanomi, Anna-Maria Capelli, Emiliano Castiglioni, Stefania Contini, Fabio Degiorgis, Pina Di Felice, Daniele Donati, Elettra Fazzolari, Gabriella Gentile, Chiara Marchionni, Carla Marchioro, Flavia Messina, Fabrizio Micheli, Beatrice Oliosi, Francesca Pavone, Alessandra Pasquarello, Benedetta Perini, Marilisa Rinaldi, Fabio M. Sabbatini, Giovanni Vitulli, Paola Zarantonello, Romano Di Fabio & Yves St-Denis. (2007) Cyclopenta[d]pyrimidines and Dihydropyrrolo[2,3-d]pyrimidines as Potent and Selective Corticotropin-Releasing Factor 1 Receptor Antagonists. ChemMedChem 2:4, pages 528-540.
Crossref
Crossref
Éva M. Fekete & Eric P. Zorrilla. (2007) Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs. Frontiers in Neuroendocrinology 28:1, pages 1-27.
Crossref
Crossref
Kathleen Chu, George F. Koob, Maury Cole, Eric P. Zorrilla & Amanda J. Roberts. (2007) Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacology Biochemistry and Behavior 86:4, pages 813-821.
Crossref
Crossref
Dimitri E. Grigoriadis & Samuel R. J. Hoare. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
R.A. Hodgson, G.A. Higgins, D.H. Guthrie, S.X. Lu, A.J. Pond, D.E. Mullins, M.F. Guzzi, E.M. Parker & G.B. Varty. (2007) Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Pharmacology Biochemistry and Behavior 86:3, pages 431-440.
Crossref
Crossref
Yvette Taché & Bruno Bonaz. (2007) Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. Journal of Clinical Investigation 117:1, pages 33-40.
Crossref
Crossref
Cindy K. Funk, Eric P. Zorrilla, Mei-Jing Lee, Kenner C. Rice & George F. Koob. (2007) Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent Rats. Biological Psychiatry 61:1, pages 78-86.
Crossref
Crossref
E.P. Zorrilla, Y. Zhao & G.F. Koob. 2007. Encyclopedia of Stress. Encyclopedia of Stress
206
214
.
Valentina Sabino, Pietro Cottone, George F. Koob, Luca Steardo, Mei J. Lee, Kenner C. Rice & Eric P. Zorrilla. (2006) Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology 189:2, pages 175-186.
Crossref
Crossref
E Zoumakis, D K Grammatopoulos & G P Chrousos. (2006) Corticotropin-releasing hormone receptor antagonists. European Journal of Endocrinology 155:suppl_1, pages S85-S91.
Crossref
Crossref
Cindy K. Funk, Laura E. O'Dell, Elena F. Crawford & George F. Koob. (2006) Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats. The Journal of Neuroscience 26:44, pages 11324-11332.
Crossref
Crossref
Victoria B. Risbrough & Murray B. Stein. (2006) Role of corticotropin releasing factor in anxiety disorders: A translational research perspective. Hormones and Behavior 50:4, pages 550-561.
Crossref
Crossref
John C. Crabbe, Tamara J. Phillips, R. Adron Harris, Michael A. Arends & George F. Koob. (2006) REVIEW: Alcohol‐related genes: contributions from studies with genetically engineered mice. Addiction Biology 11:3-4, pages 195-269.
Crossref
Crossref
Jean-Philippe Vit, Daniel J. Clauw, Theodore Moallem, Abdenasser Boudah, Peter T. Ohara & Luc Jasmin. (2006) Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats. Pain 121:3, pages 241-260.
Crossref
Crossref
Jishi Wang, Qin Fang, Zhonghua Liu & Lin Lu. (2005) Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology 185:1, pages 19-28.
Crossref
Crossref
Darci M. Nielsen. (2006) Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?. Life Sciences 78:9, pages 909-919.
Crossref
Crossref
Y. St-Denis, R. Di Fabio, G. Bernasconi, E. Castiglioni, S. Contini, D. Donati, E. Fazzolari, G. Gentile, D. Ghirlanda, C. Marchionni, F. Messina, F. Micheli, F. Pavone, A. Pasquarello, F.M. Sabbatini, M.G. Zampori, R. Arban & G. Vitulli. (2005) Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxiety. Bioorganic & Medicinal Chemistry Letters 15:16, pages 3713-3716.
Crossref
Crossref
Juan M. Saavedra & Jaroslav Pavel. (2005)
Angiotensin II AT
1
receptor antagonists inhibit the angiotensin‐CRF‐AVP axis and are potentially useful for the treatment of stress‐related and mood disorders
. Drug Development Research 65:4, pages 237-269.
Crossref
Crossref
Glenn R. Valdez, Eric P. Zorrilla & George F. Koob. (2005)
Homeostasis within the corticotropin‐releasing factor system via CRF
2
receptor activation: a novel approach for the treatment of anxiety
. Drug Development Research 65:4, pages 205-215.
Crossref
Crossref
Stephen D. Fox, John M. Roman, Giovanni Cizza, Timothy D. Veenstra & Haleem J. Issaq. (2005) Quantitative determination of antalarmin, a novel corticotropin‐releasing hormone receptor‐1 antagonist, in canine plasma by HPLC‐MS. Journal of Separation Science 28:4, pages 332-336.
Crossref
Crossref
E. P. Zorrilla. (2004) Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity. Journal of Pharmacology and Experimental Therapeutics 310:3, pages 1027-1034.
Crossref
Crossref